My current research focuses on developing new diagnostic assays to aid in the early and accurate diagnosis of dementia. More broadly, I am interested in the contribution of early-life environmental factors (e.g., sickness, socio-economic statues, diet) in the development of neurodegenerative disease.
As a member of the Canadians Saving Arrest Victims Everywhere (CanSAVE) Novel Biosensor project, Mahsa's research is focused on developing wearable technologies to detect out-of-hospital sudden cardiac arrest incidents. This work involves (1) designing wearable sensors to collect bio-signals associated with cardiac arrest conditions (e.g., electrocardiogram, breathing rate); and (2) using machine learning to identify appropriate combinations of collected bio-signals to detect a sudden cardiac arrest event.
Mechanisms mediating hyperinsulinemia and metabolic dysfunction in physical inactivity.
Investigating the role of the anterior cingulate cortex and ventral tegmental area in motivation and decision-making
I am interested in tumour immunology and innervation.
Repair of Myocadial Infraction; Heart complications caused by SARS-COV-2
Hao is a postdoctoral researcher in the School of Population and Public Health at the University of British Columbia. Hao’s research applies interdisciplinary methods combine epidemiological knowledge and economic valuation methods with high-resolution data to investigate the social costs of leading environmental risks. The results of her research provide economic justifications for policymakers to balance environmental conservation and economic development while advancing social equity and environmental sustainability.
The interplay between epigenetic marks during early mouse development, specifically focussing on epigenetic reprogramming in the early embryo in the context of developmental disorders and syndromes.
Dr. Sofia Bartlett is a postdoctoral research fellow in the clinical prevention services division at the British Columbia Centre for Disease Control and Department of Pathology and Laboratory Medicine at the University of British Columbia. She obtained her Doctorate degree (PhD) in Molecular Epidemiology at the Kirby Institute, University of New South Wales in Sydney, Australia. Her research focusses on improving the health of marginalised populations, such as people who inject drugs, people in prison, and people living with hepatitis C infection.
Identifying Clinical Pharmacogenomic Predictors for Antibiotic-associated Severe Cutaneous Adverse Drug Reactions: An International Cohort Pilot Study